author-photo

Yok-Lam Kwong

University of Hong Kong
Queen Mary Hospital

494

Papers

14637

Citations

Citation Trend

Filter By

Papers (494) Sort By

Journal Conference Others

Use of Positron Emission Tomography in Patients with Classical Hodgkin Lymphoma Outside of Europe and North America: Results from the International, Multi-Center, Retrospective B-Holistic Study

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
3-weekly daratumumab-lenalidomide/pomalidomide-dexamethasone is highly effective in relapsed and refractory multiple myeloma

2021 Hematology
Show All
- Source
- Cite
- Save
Citations (0)
Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling

2021 Elements
Show All
- Source
- Cite
- Save
Citations (0)
P-181: Treatment outcome and prognostic factors of newly diagnosed Multiple Myeloma receiving Bortezomib-based induction in Hong Kong: an analysis of 448 patients

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 833: Characterization of the humoral immune response to the EBV proteome in extranodal natural killer T-cell lymphoma

2021 Epidemiology
Show All
- Source
- Cite
- Save
Citations (0)
Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Mutation profile of acute myeloid leukaemia in a Chinese cohort by targeted next-generation sequencing.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 487: Genomic difference of CD4 CD8 double-positive T cells versus conventional CD4 T cells and CD8 T cells in responders undergoing immunotherapy in advanced HCC

2021
Show All
- Source
- Cite
- Save
Citations (0)
Ruxolitinib (RUX) Vs Best Available Therapy (BAT) in Patients With Steroid-refractory Acute GRAFT-VS-HOST Disease (SR-AGVHD): 6-Month Follow-up From The Randomized, Phase 3 Reach2 Study

2021 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study.

2021 Journal of Hematology & Oncology
Show All
- Source
- Cite
- Save
Citations (3)